This edition highlights:
SpaceX’s landmark public listing is lifting space sector valuations while European firms navigate stricter sustainability and governance hurdles.
Transatlantic pharmaceutical competition is accelerating around obesity therapies as expanding health coverage fuels patient demand.
American export curbs on advanced artificial intelligence models are intensifying European efforts to build sovereign computing capabilities.
Major European carmakers are uniting to demand regional manufacturing preferences to counter record import imbalances.
